Baxter International Inc. (BAX)

NYSE · Medical Instruments & Supplies

23.00
-0.50 (-2.13%)
Updated Oct 31, 5:52 PM ET
AI Rating
Strong Buy
Overall Score
81
Trend
73
Momentum
89
Risk
81

Scores are generated from technical indicators for educational purposes and are not a recommendation to buy or sell.

Price history

Daily closes and volume
Oct 16, 2025 260 sessions Oct 28, 2026

AI Analysis

Baxter International Inc. is trading at $23.00, down 2.13% on the session. The 50 day average sits at $24.71 and the 200 day at $21.30, which puts the stock in a uptrend. RSI is at 57.5, which reads as strong, and MACD is bullish crossover. Volume is volume spike.

The nearest support is around $25.17 with resistance near $25.71, so that band frames the current range. Average daily movement is roughly $0.75, or about 3.3% of the share price, which is what any stop placement has to allow for. The overall health score of 81 out of 100 combines a trend score of 73, momentum of 89 and a risk score of 81.

Technical indicators

RSI (14)
57.5
strong
MACD
0.271
bullish crossover
SMA 20
24.71
SMA 50
24.71
SMA 200
21.30
uptrend
ATR (14)
0.75
avg daily range
Support
25.17
Resistance
25.71
Volume vs 20d
2.10x
volume spike
Volatility
29.8%
annualised
1 month
+8.43%
3 months
-4.82%

AI trade signals on BAX

All signals
Date Setup Entry Target Stop R:R Status
Oct 28 Momentum ••.•• ••.•• ••.•• 4.26:1 Open

About Baxter International Inc.

Baxter International Inc., through its subsidiaries, provides a portfolio of healthcare products in the United States. The company operates through three segments: Medical Products & Therapies, Healthcare Systems & Technologies, and Pharmaceuticals. It offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; inhaled anesthetics; generic injectable pharmaceuticals; surgical hemostat and sealant products; advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space comprising operating room integration technologies, precision positioning devices, and other accessories. The company also provides specialty injectable pharmaceuticals, inhaled anesthetics, and drug compounding services. Its products are used in hospitals, nursing homes, rehabilitation centers, ambulatory surgery centers, doctors' offices, kidney dialysis centers, and patients at home under physician supervision. The company sells its products through direct sales force, independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers. It operates in Eastern Europe, the Middle East, Africa, Latin America, Asia, Western Europe, Canada, Japan, Australia, and New Zealand. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.

Company website

Stay Ahead of the Market

Get daily AI insights, market updates, and trade opportunities delivered to your inbox.